Sortino ratio is not yet available for PBLS. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar stocks
The table compares Parabilis Medicines, Inc.'s Sortino Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how PBLS's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jul 25, 2026.
| Symbol | Name | 1Y Sortino Ratio | 5Y Sortino Ratio | 10Y Sortino Ratio | All Time Sortino Ratio |
|---|---|---|---|---|---|
| ANEB | Anebulo Pharmaceuticals, Inc. | 557.92 | |||
| CARM | Carisma Therapeutics Inc. | 76.12 | |||
| NKGN | NKGen Biotech Inc. Common Stock | 7.70 | |||
| RVMD | Revolution Medicines, Inc. | 6.56 | |||
| CAPR | Capricor Therapeutics, Inc. | 6.49 | |||
| RVMDW | Revolution Medicines Inc. Warrant | 6.44 | |||
| ROIV | Roivant Sciences Ltd. | 6.43 | |||
| PRAX | Praxis Precision Medicines, Inc. | 6.08 | |||
| ALMS | Alumis Inc | 6.01 | |||
| COGT | Cogent Biosciences, Inc. | 5.67 | |||
| PBLS | Parabilis Medicines, Inc. | — |
Historical Sortino Ratio
The chart shows PBLS's rolling Sortino ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to downside risk, while declining trends may signal deteriorating risk-adjusted performance or increased volatility during market stress. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.
Identify market cycles by observing when PBLS consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.
Loading charts...
IHow does PBLS fit in your portfolio?
Add your other holdings to see your portfolio's Sortino Ratio and find out.
Analyze Your Portfolio